Literature DB >> 26342673

A functional proteomics approach to the comprehension of sarcoidosis.

C Landi1, E Bargagli2, A Carleo2, L Bianchi3, A Gagliardi3, G Cillis2, M G Perari2, R M Refini2, A Prasse4, L Bini3, P Rottoli2.   

Abstract

Pulmonary sarcoidosis (Sar) is an idiopathic disease histologically typified by non-caseating epitheliod cell sarcoid granulomas. A cohort of 37 Sar patients with chronic persistent pulmonary disease was described in this study. BAL protein profiles from 9 of these Sar patients were compared with those from 8 smoker (SC) and 10 no-smoker controls (NSC) by proteomic approach. Principal Component Analysis was performed to clusterize the samples in the corresponding conditions highlighting a differential pattern profiles primarily in Sar than SC. Spot identification reveals thirty-four unique proteins involved in lipid, mineral, and vitamin Dmetabolism, and immuneregulation of macrophage function. Enrichment analysis has been elaborated by MetaCore, revealing 14-3-3ε, α1-antitrypsin, GSTP1, and ApoA1 as "central hubs". Process Network as well as Pathway Maps underline proteins involved in immune response and inflammation induced by complement system, innate inflammatory response and IL-6signalling. Disease Biomarker Network highlights Tuberculosis and COPD as pathologies that share biomarkers with sarcoidosis. In conclusion, Sar protein expression profile seems more similar to that of NSC than SC, conversely to other ILDs. Moreover, Disease Biomarker Network revealed several common features between Sar and TB, exhorting to orientate the future proteomics investigations also in comparative BALF analysis of Sar and TB.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bronchoalveolar lavage; Functional proteomics; Mass spectrometry; Pathway analysis; Sarcoidosis; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26342673     DOI: 10.1016/j.jprot.2015.08.012

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  13 in total

1.  Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.

Authors:  Yoshihisa Nukui; Yasunari Miyazaki; Kozo Suhara; Tsukasa Okamoto; Haruhiko Furusawa; Naohiko Inase
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  NK and NKT-like cells in granulomatous and fibrotic lung diseases.

Authors:  L Bergantini; P Cameli; M d'Alessandro; C Vagaggini; R M Refini; C Landi; M G Pieroni; M Spalletti; P Sestini; E Bargagli
Journal:  Clin Exp Med       Date:  2019-09-04       Impact factor: 3.984

Review 3.  Sarcoidosis: a review for the internist.

Authors:  Elena Bargagli; Antje Prasse
Journal:  Intern Emerg Med       Date:  2018-01-03       Impact factor: 3.397

4.  Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles.

Authors:  Yu Futami; Yoshito Takeda; Taro Koba; Ryohei Narumi; Yosui Nojima; Mari Ito; Mana Nakayama; Mimiko Ishida; Hanako Yoshimura; Yujiro Naito; Kiyoharu Fukushima; Takayuki Takimoto; Ryuya Edahiro; Takanori Matsuki; Satoshi Nojima; Haruhiko Hirata; Shohei Koyama; Kota Iwahori; Izumi Nagatomo; Yuya Shirai; Yasuhiko Suga; Shingo Satoh; Shinji Futami; Kotaro Miyake; Takayuki Shiroyama; Yoshikazu Inoue; Jun Adachi; Takeshi Tomonaga; Koji Ueda; Atsushi Kumanogoh
Journal:  Int Immunol       Date:  2022-06-04       Impact factor: 5.071

5.  ASIC1 promotes differentiation of neuroblastoma by negatively regulating Notch signaling pathway.

Authors:  Mingli Liu; Koichi Inoue; Tiandong Leng; An Zhou; Shanchun Guo; Zhi-Gang Xiong
Journal:  Oncotarget       Date:  2017-01-31

6.  Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.

Authors:  Ana Sofia Carvalho; Célia Marina Cuco; Carla Lavareda; Francisco Miguel; Mafalda Ventura; Sónia Almeida; Paula Pinto; Tiago Tavares de Abreu; Luís Vaz Rodrigues; Susana Seixas; Cristina Bárbara; Mikel Azkargorta; Felix Elortza; Júlio Semedo; John K Field; Leonor Mota; Rune Matthiesen
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

7.  Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis.

Authors:  Min Zhao; Xin Di; Xin Jin; Chang Tian; Shan Cong; Jiaying Liu; Ke Wang
Journal:  Med Sci Monit       Date:  2020-07-23

8.  Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis.

Authors:  Yasushi Horimasu; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Takeshi Masuda; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

9.  Novel protein pathways in development and progression of pulmonary sarcoidosis.

Authors:  Maneesh Bhargava; K J Viken; B Barkes; T J Griffin; M Gillespie; P D Jagtap; R Sajulga; E J Peterson; H E Dincer; L Li; C I Restrepo; B P O'Connor; T E Fingerlin; D M Perlman; L A Maier
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

10.  The effects of exercise training on lipid profile in patients with sarcoidosis.

Authors:  Dariusz Jastrzebski; Beata Toczylowska; Elzbieta Zieminska; Aleksandra Zebrowska; Sabina Kostorz-Nosal; Elzbieta Swietochowska; Camillo Di Giulio; Dariusz Ziora
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.